The unstoppable Hims & Hers notches another rise with wider GLP-1 med access. Hims announced a deal with Eli Lilly to fulfill Zepbound prescriptions via Lilly Direct. It also permits its providers to ...
When research papers, apparently AI-generated, are being fraudulently posted with names as prominent as Dr. Eric Topol’s plus five other authors, for content that is clearly academic-appearing ...
A two-year+ story about teleprescriber illegalities that isn’t getting near enough attention. The Cerebral saga is far from over. Telehealth prescriber Zealthy, founded by former Cerebral CEO Kyle ...
In fact the Monkey rates Teladoc “among the best medical AI stocks to buy now”. The article is an overview of the Pineal Capital Management call for $200 million in share buybacks, breaking up the ...
Save the dates, be a speaker, and book the tickets! One of the oldest international organizations in digital health, ISfTeH (the International Society for Telemedicine & eHealth) is meeting again for ...
A JAMA Network study published in October 2025, with data collected in 2024, on ambient AI scribes found that documentation load directly erodes the attention providers can bring to each encounter.
With the $50 million funding, Boehringer turned over commercialization to Click. What is odd here is that companies with investigational tech and large partners usually keep the staff lean.
Telehealth and Telecare Aware posts pointers to a broad range of news items. Authors of those items often use terms 'telecare' and telehealth' in inventive and idiosyncratic ways. Telecare Aware's ...
Telehealth and Telecare Aware posts pointers to a broad range of news items. Authors of those items often use terms 'telecare' and telehealth' in inventive and idiosyncratic ways. Telecare Aware's ...